The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …

Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary
endpoints and are increasingly recognized by regulators, clinicians, and patients as …

PURPOSE APHINITY, at 45 months median follow-up, showed that pertuzumab added to
adjuvant trastuzumab and chemotherapy significantly improved invasive disease–free …

The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …

Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …

On request of the French Health Ministry, the French High Council for Public health (Haut
Conseil de Santé Publique [HCSP]) entrusted a representative group of French medical …

Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women,
respectively, thus representing the 7th most common cancer in men, and the 10th most …

Healthcare decision making is complex. Decision-making processes and the factors
(criteria) that decision makers should consider vary for different types of decisions, including …

ABSTRACT Background The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS)
version 1.0 (v1. 0) was published in May 2015 and was the first version of a validated and …

Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …